NEW YORK--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced three corporate governance additions to further position the organization…
NEW YORK & GREENVILLE, S.C.--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced a partnership with youturn,…
FEBRUARY | 24 | 2021 Primary objective of the Mirai study is to evaluate the effectiveness of digital therapeutics to reduce depressive symptoms in adults…
New York, New York, – December 01, 2020 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced…
First Integrated Pharmacogenomics and Metabolomics Platform Offers Potential to Improve Patient Outcomes, Lower Costs in Medication Therapy Ann Arbor, MI – November 14, 2019 –…
Ann Arbor, MI – January 22, 2019 – Dr. Brian D. Athey, co-founder and Chief Science & Technology Officer of Phenomics Health Inc. (PHI), presented…